Advancements in transdermal drug delivery systems: Enhancing medicine with pain-free and controlled drug release

Abstract

Transdermal Drug Delivery Systems (TDDSs) provide controlled and prolonged drug release, enhance patient compliance, reduce gastrointestinal side effects, and improve drug stability. By delivering medication directly through the skin, TDDSs avoid the initial breakdown of the drug in the liver, which can enhance the amount of medication that reaches the bloodstream. The noninvasive nature of TDDSs reduces discomfort for patients by eliminating the need for invasive procedures like injections, enabling uninterrupted use throughout the day. Innovations such as the development of microneedles with adjustable depths and nanoparticles with targeted drug delivery capabilities have significantly improved the accuracy and efficiency of TDDSs. TDDSs have potential applications beyond pain management, including treating chronic conditions such as diabetes and hypertension.

Keywords

Transdermal Drug delivery systems / Controlled drug release / Medication adherence / Patient outcomes / Microneedles / Nanoparticles

References

[1] Kalia Y. Modeling transdermal drug release. Ad Drug Delivery Rev. 2001; 48: 159- 172.

[2] Shingade GM. Review on recent trends in transdermal drug delivery systems. J of Drug Delivery and The. 2012; 2 (1): 66- 75.

[3] Esuendale D, Gabriel T. Cellulosic on transdermal drug delivery system:a review. J of Drug Delivery and The. 2016; 6: 57- 64.

[4] Manikkath J, Subramony JA. Toward closed-loop drug delivery:integrating wearable technologies with transdermal drug delivery systems. Ad Drug Delivery Rev. 2021; 179: 113997.

[5] Benson H. Transdermal drug delivery:penetration enhancement techniques. Cur Drug Del. 2005; 2: 23- 33.

[6] Prausnitz MR. Microneedles for transdermal drug delivery. Ad Drug Del Rev. 2004; 56: 581- 587.

[7] Tiwari C, Choudhary M, Malik P, Jaiswal PK, Chauhan R. Transdermal patch:a novel approach for transdermal drug delivery. J of Drug Del and The. 2022; 12: 179- 188.

[8] Higo N. The recent trend of transdermal drug delivery system development. ChemInform. 2007; 38: 655- 662.

[9] Muzzalupo R, Tavano L. Niosomal drug delivery for transdermal targeting:recent advances. Res and Rep in Trans Drug Del. 2015; 4: 23- 33.

[10] Murthy. . Transdermal drug delivery:approaches and significance. Res and Rep in Trans Drug Del. 2012; 2: 1- 2.

[11] Langer R. Transdermal drug delivery:past progress, current status, and future prospects. Ad Drug Del Rev. 2004; 56: 557- 558.

[12] Ramadon D, Mccrudden MTC, Courtenay AJ, Donnelly RF. Enhancement strategies for transdermal drug delivery systems:current trends and applications. Drug Del and Trans Res. 2021; 12: 758- 791.

[13] Liu K, Wang H, Zhu F, et al. Lab on the microneedles:a wearable metal-organic frameworks-based sensor for visual monitoring of stress hormone. ACS Nano. 2024; 18: 14207- 14217.

[14] Prausnitz MR, Langer R. Transdermal drug delivery. Nature Biotech. 2008; 26: 1261- 1268.

[15] Prausnitz MR, Mitragotri S, Langer R. Current status and future potential of transdermal drug delivery. Nat Rev Drug Dis. 2004; 3: 115- 124.

[16] Zhang L, Li Y, Wei F, et al. Transdermal delivery of salmon calcitonin using a dissolving microneedle array:characterization, stability, and in vivo pharmacodynamics. AAPS PharmSciTech. 2020; 22 (1): 1- 10.

[17] Chaturvedi S, Garg A. An insight into techniques for the assessment of permeation flux across the skin for optimization of topical and transdermal drug delivery systems. J of Drug Del Science and Tech. 2021; 62: 102355.

[18] Kumar R, Sinha VR, Dahiya L, Sarwal A. Transdermal delivery of duloxetinesulfobutylether-β-cyclodextrin complex for effective management of depression. Inter J of Pharm. 2021; 594: 120129.

[19] Zhang Q, Shi L, He H, et al. Down-regulating scar formation by microneedles directly via a mechanical communication pathway. ACS Nano. 2022; 16: 10163- 10178.

[20] Shen C-C, Yang Y-C, Huang T-B, Chan S-C, Liu B-S. Low-level laser-accelerated peripheral nerve regeneration within a reinforced nerve conduit across a large gap of the transected sciatic nerve in rats. Evidence-Based Comp Alter Med. 2013; 2013: 1- 12.

[21] Abdullah HM, Farooq M, Adnan S, et al. Development and evaluation of reservoir transdermal polymeric patches for controlled delivery of diclofenac sodium. Polymer Bull. 2022; 80: 6793- 6818.

[22] Umeyor CE, Shelke V, Pol A, et al. Biomimetic microneedles:exploring the recent advances on a microfabricated system for precision delivery of drugs, peptides, and proteins. Fut J of Pharm Sci. 2023; 9.

[23] Zuidema JM, Kumeria T, Kim D, et al. Oriented Nanofibrous Polymer Scaffolds Containing Protein-Loaded Porous Silicon Generated by Spray Nebulization. vol. 30. Ad Material; 2018: e1706785.

[24] Wong FSY, Tsang KK, Chu AMW, Chan BP, Yao KM. Injectable cell-encapsulating composite alginate-collagen platform with an inducible termination switch for safer ocular drug delivery. Biomaterial. 2019; 201: 53- 67.

[25] Chen C, Liu Y, Wang H, et al. Multifunctional chitosan inverse opal particles for wound healing. ACS Nano. 2018; 12: 10493- 10500.

[26] Bozuyuk U, Yasa O, Yasa IC, Ceylan H, Kizilel S, Sitti M. Light-triggered drug release from 3D-printed magnetic chitosan microswimmers. ACS Nano. 2018; 12: 9617- 9625.

[27] Zhang S, Xin P, Ou Q, Hollett G, Gu Z, Wu J. Poly(ester amide)-based hybrid hydrogels for efficient transdermal insulin delivery. J of Material Chem B. 2018; 6: 6723- 6730.

[28] Karpinski T. Selected medicines used in iontophoresis. Pharmaceutics. 2018; 10: 204.

[29] Ita K. Perspectives on transdermal electroporation. Pharmaceutics. 2016; 8: 9.

[30] Zhu Z, Wang J, Pei X, et al. Blue-ringed octopus-inspired microneedle patch for robust tissue surface adhesion and active injection drug delivery. Sci Adv. 2023; 9.

[31] Chen X, Zhu L, Li R, et al. Electroporation-enhanced transdermal drug delivery:effects of logP, pKa, solubility, and penetration time. Euro J of Pharm Science. 2020; 151: 105410.

[32] Schoellhammer CM, Srinivasan S, Barman R, et al. Applicability and safety of dualfrequency ultrasonic treatment for the transdermal delivery of drugs. J of Controlled Release. 2015; 202: 93- 100.

[33] Kurian AG, Singh RK, Sagar V, Lee J-H, Kim H-W. Nanozyme-engineered hydrogels for anti-inflammation and skin regeneration. Nano-Micro Lett. 2024; 16.

[34] Zhao Y, Zhou Y, Yang D, et al. Intelligent and spatiotemporal drug release based on multifunctional nanoparticle-integrated dissolving microneedle system for synergetic chemo-photothermal therapy to eradicate melanoma. Acta Biomater. 2021; 135: 164- 178.

[35] Jung H, Kim MK, Lee JY, Choi SW, Kim J. Hydrogel patch:adhesive hydrogel patch with enhanced strength and adhesiveness to skin for transdermal drug delivery. Ad Function Materials. 2020; 30: 2004407.

[36] Liu G, Zhou Y, Xu Z, Bao Z, Zheng L, Wu J. Janus hydrogel with dual antibacterial and angiogenesis functions for enhanced diabetic wound healing. Chin Chem Lett. 2023; 34: 107705.

[37] Cao D, Chen X, Cao F, et al. An intelligent transdermal formulation of ALA-loaded copolymer thermogel with spontaneous asymmetry by using temperature-induced sol-gel transition and gel-sol (suspension) transition on different sides. Adv Funct Mater. 2021; 31: 2100349.

[38] Martí-Centelles R, Dolz-Pérez I, Dela OJ, et al. Two-component peptidic molecular gels for topical drug delivery of naproxen. ACS Appl Bio Mater. 2021; 4: 935- 944.

[39] Jiang H, Ochoa M, Waimin JF, Rahimi R, Ziaie B. A pH-regulated drug delivery dermal patch for targeting infected regions in chronic wounds. Lab Chip. 2019; 19: 2265- 2274.

[40] Dhal S, Verma P, Mishra M, Giri S. Oleogel-mediated transdermal delivery of white emitting NaYF4 conjugated with Rose Bengal for the generation of reactive oxygen species through NIR-upconversion. Colloids Surf B Biointerfaces. 2020; 190: 110945.

[41] Bao Z, Gu Z, Xu J, Zhao M, Liu G, Wu J. Acid-responsive composite hydrogel platform with space-controllable stiffness and calcium supply for enhanced bone regeneration. Chem Eng J. 2020; 396: 125353.

[42] Xu Y, Chen H, Fang Y, Wu J. Hydrogel combined with phototherapy in wound healing. Adv Healthc Mater. 2022; 11: 34- 38.

[43] Li M, Liu X, Tan L, et al. Noninvasive rapid bacteria-killing and acceleration of wound healing through photothermal/photodynamic/copper ion synergistic action of a hybrid hydrogel. Biomater Sci. 2018; 6: 2110- 2121.

[44] Zhang Y, Wang J, Yu J, et al. Bioresponsive microneedles with a sheath structure for H2O₂ and pH cascade-triggered insulin delivery. Small. 2018; 14.

[45] Yang C, Sheng T, Hou W, et al. Glucose-responsive microneedle patch for closedloop dual-hormone delivery in mice and pigs. Sci Adv. 2022; 8: 65- 72.

[46] Li W, Terry RN, Tang J, Feng MR, Schwendeman SP, Prausnitz MR. Rapidly separable microneedle patch for the sustained release of a contraceptive. Nat Biomed Eng. 2019; 3: 220- 229.

[47] Bolton CJW, Howells O, Blayney GJ, et al. Hollow silicon microneedle fabrication using advanced plasma etch technologies for applications in transdermal drug delivery. Lab Chip. 2020; 20: 2788- 2795.

[48] Resnik D, Možek M, Pečar B, et al. In vivo experimental study of noninvasive insulin microinjection through hollow Si microneedle array. Micromachines. 2018; 9: 40.

[49] Yeung C, Chen S, King B, et al. A 3D-printed microfluidic-enabled hollow microneedle architecture for transdermal drug delivery. Biomicrofluidics. 2019; 13: 064125.

[50] Jayaneththi VR, Aw K, Sharma M, Wen J, Svirskis D, McDaid AJ. Controlled transdermal drug delivery using a wireless magnetic microneedle patch:preclinical device development. Sens Actuators B Chem. 2019; 297: 126708.

[51] Dong CW, Jeon JY, Kang HM, Park WT. Tip fabrication methods of hollow metal microneedles. J Mech Sci Technol. 2022; 37: 261- 269.

[52] Choi IJ, Kang A, Ahn MH, et al. Insertion-responsive microneedles for rapid intradermal delivery of canine influenza vaccine. J Control Release. 2018; 286: 460- 466.

[53] Chen Z, He J, Qi J, Zhu Q, Wu W, Lu Y. Long-acting microneedles:a progress report of the state-of-the-art techniques. Drug Discov Today. 2020; 25: 1462- 1468.

[54] Wang M, Han Y, Yu X, et al. Upconversion nanoparticle powered microneedle patches for transdermal delivery of siRNA. Adv Healthc Mater. 2019; 9.

[55] Yang J, Chen Z, Ye R, et al. Touch-actuated microneedle array patch for closed-loop transdermal drug delivery. Drug Deliv. 2018; 25: 1728- 1739.

[56] Liu T, Chen M, Fu J, et al. Recent advances in microneedles-mediated transdermal delivery of protein and peptide drugs. Acta Pharm Sin B. 2021; 11: 2326- 2343.

[57] Kusama S, Sato K, Matsui Y, et al. Transdermal electroosmotic flow generated by a porous microneedle array patch. Nat Commun. 2021; 12: 1- 11.

[58] Xu C, Song Y, Han M, Zhang H. Portable and wearable self-powered systems based on emerging energy harvesting technology. Micro Nano Eng. 2021; 7: 25.

[59] Xu G, Lu Y, Cheng C, et al. Battery-free and wireless smart wound dressing for wound infection monitoring and electrically controlled on-demand drug delivery. Adv Funct Mater. 2021; 31: 2100852.

[60] Yang Y, Xu L, Jiang D, et al. Self-Powered controllable transdermal drug delivery system. Adv Funct Mater. 2021; 31: 2104092.

[61] Almatroudi A. Investigating biofilms:advanced methods for comprehending microbial behavior and antibiotic resistance. Front in Bio-Land. 2024; 29: 133.

[62] Lim C, Hong YJ, Jung J, et al. Tissue-like skin-device interface for wearable bioelectronics by using ultrasoft, mass-permeable, and low-impedance hydrogels. Sci Adv. 2021; 7.

[63] Liu Z, Nie J, Miao B, et al. Self-Powered intracellular drug delivery by a biomechanical energy-driven triboelectric nanogenerator. Adv Mater. 2019; 31: 1807795.

[64] Park G, Zhang KK, Lee H. Review:consideration of nanomedicine, its past and future, and its application possibilities. J Med Imaging. 2023; 6: 27- 34.

[65] Ning X, Chen S, Yang Y, et al. Photodynamic bubble-generating microneedles for enhanced transdermal cancer therapy. ACS Appl Polym Mater. 2021; 3: 6502- 6512.

[66] Choi G, Fitriasari EI, Park C. Electro-mechanochemical gating of a metal-phenolic nanocage for controlled guest-release self-powered patches and injectable gels. ACS Nano. 2021; 15: 14580- 14586.

[67] Hu Y, Mo Y, Wei J, Yang M, Zhang X, Chen X. Programmable and monitorable intradermal vaccine delivery using ultrasound perforation array. Int J Pharm. 2022; 617: 121595.

[68] Hu Y, Yang M, Huang H, Shen Y, Liu H, Chen X. Controlled ultrasound erosion for transdermal delivery and hepatitis B immunization. Ultrasound Med Biol. 2019; 45: 1208- 1220.

[69] Soto F, Jeerapan I, Silva-Lopez C, Lopez-Ramirez MA, Chai I, Wang J. Noninvasive transdermal delivery system of lidocaine using an acoustic droplet-vaporization based wearable patch. Small. 2018; 14.

[70] Cai X, Jiang Y, Lin M, et al. Ultrasound-responsive materials for drug/gene delivery. Front Pharmacol. 2020; 10: 1650.

[71] Jin Y, Lu Y, Jiang X, et al. Accelerated infected wound healing by probiotic-based living microneedles with long-acting antibacterial effect. Biomaterials. 2024; 38: 292- 304.

[72] Kumar B, Singh SK, Prakash T, et al. Pharmacokinetic and pharmacodynamic evaluation of Solid self-nanoemulsifying delivery system (SSNEDDS) loaded with curcumin and duloxetine in attenuation of neuropathic pain in rats. Neurol Sci. 2020; 42: 1785- 1797.

[73] Xu Y, Zhao M, Cao J, et al. Applications and recent advances in transdermal drug delivery systems for the treatment of rheumatoid arthritis. Acta Pharm Sin B. 2023; 13: 4417- 4441.

[74] Mahmoud EA, Bendas ER, Mohamed MI. Effect of formulation parameters on the preparation of superporous hydrogel self-nanoemulsifying drug delivery system (SNEDDS) of carvedilol. AAPS PharmSciTech. 2010; 11: 221- 225.

[75] Ma Y, Li C, Mai Z, Yang J, Tai M, Leng G. Efficacy and safety testing of dissolving microarray patches in Chinese subjects. J of Cos Derma. 2021; 21: 3496- 3502.

[76] Kaur P, Singh SK, Garg V, Gulati M, Vaidya Y. Optimization of spray drying process for formulation of solid dispersion containing polypeptide-k powder through quality by design approach. Powder Technol. 2015; 284: 1- 11.

[77] Lim C, Lee D, Kim M, et al. Development of a sorafenib-loaded solid selfnanoemulsifying drug delivery system:formulation optimization and characterization of enhanced properties. J Drug Deliv Sci Technol. 2023; 82: 104374.

[78] Karthika C, Sureshkumar R, Suhail A. Formulation development and in vitro evaluation of curcumin-loaded solid self-nanoemulsifying drug delivery system for colon carcinoma. Asian J Pharm Clin Res. 2019; 12: 243- 247.

[79] Singh S, Mishra JN. Formulation and evaluation of self-nanoemulsifying dual drug delivery system of celecoxib and curcumin. J Popul Ther Clin Pharmacol. 2023; 30: 726- 740.

[80] Kalamkar R, Wadher S. Formulation and pharmacokinetic evaluation of phosal based zaltoprofen solid self-nanoemulsifying drug delivery system. Pharm Nanotechnol. 2019; 7: 328- 338.

[81] Kaur N, Garg T, Goyal AK, Rath G. Formulation, optimization and evaluation of curcumin-β-cyclodextrin-loaded sponge for effective drug delivery in thermal burns chemotherapy. Drug Deliv. 2014; 23: 2245- 2254.

[82] Verma R, Kaushik D. Design and optimization of candesartan loaded selfnanoemulsifying drug delivery system for improving its dissolution rate and pharmacodynamic potential. Drug Deliv. 2020; 27: 756- 771.

[83] Patel G, Shelat P, Lalwani A. Statistical modeling, optimization and characterization of solid self-nanoemulsifying drug delivery system of lopinavir using design of experiment. Drug Deliv. 2016; 23: 3027- 3042.

[84] Kumar R, Khursheed R, Kumar R, et al. Self-nanoemulsifying drug delivery system of fisetin:formulation, optimization, characterization and cytotoxicity assessment. J Drug Deliv Sci Technol. 2019; 54: 101252.

[85] Kazi M, Alqahtani A, Ahmad A, et al. Development and optimization of sitagliptin and dapagliflozin loaded oral self-nanoemulsifying formulation against type 2 diabetes mellitus. Drug Deliv. 2020; 28: 100- 114.

[86] Garg V, Kaur P, Singh SK, et al. Solid self-nanoemulsifying drug delivery systems for oral delivery of polypeptide-k:formulation, optimization, in-vitro and in-vivo antidiabetic evaluation. Eur J Pharm Sci. 2017; 109: 297- 315.

[87] Garg V, Kaur P, Gulati M, et al. Coadministration of polypeptide-k and curcumin through solid self-nanoemulsifying drug delivery system for better therapeutic effect against diabetes mellitus:formulation, optimization, biopharmaceutical characterization, and pharmacodynamic assessment. Assay Drug Dev Technol. 2019; 17: 201- 221.

[88] Karthika KK, Binoy Varghese C, Rajeshkumarc S, Meenaloshini G. A review on selenium nanoparticles and their biomedical applications. Bio Tech. 2024; 6: 61- 74.

[89] Anandachockalingam A, Shanmugam R, Ryntathiang I, Jothinathan MKD. Green synthesis of silver nanoparticles using zingiber officinale and ocimum gratissimum formulation for its anti-inflammatory and antidiabetic activity:an in vitro study. Cureus. 2024; 16: 1- 9.

[90] Escobar-Chavez J, Diaz-Torres R, Rodriguez-Cruz IM, et al. Nanocarriers for transdermal drug delivery. Res Rep Transderm Drug Deliv. 2012; 3.

[91] Kutner N, Kunduru KR, Rizik L, Farah S. Recent advances for improving functionality, biocompatibility, and longevity of implantable medical devices and deliverable drug delivery systems (adv. Funct. Mater. 44/2021). Adv Funct Mater. 2021; 31: 2010929.

[92] Jeong WY, Kwon M, Choi HE, Kim KS. Recent advances in transdermal drug delivery systems:a review. Biomater Res. 2021; 25: 24.

[93] Kenry Duan Y, Liu B. Biological imaging:recent advances of optical imaging in the second near-infrared window (adv. Mater. 47/2018). Adv Mater. 2018; 30.

[94] Drotlef D, Amjadi M, Yunusa M, Sitti M. Bioinspired composite microfibers for skin adhesion and signal amplification of wearable sensors. Adv Mater. 2017; 29.

[95] Tapfumaneyi P, Imran M, Mohammed Y, Roberts MS. Recent advances and future prospective of topical and transdermal delivery systems. Front Drug Deliv. 2022; 2: 1- 8.

[96] Szycher M. Recent advances in transdermal delivery systems. J Biomater Appl. 1986; 1: 207- 238.

[97] Manikkath J, Subramony JA. Toward closed-loop drug delivery:integrating wearable technologies with transdermal drug delivery systems. Adv Drug Deliv Rev. 2021; 179: 113997.

[98] Hadgraft J, Lane ME. Passive transdermal drug delivery systems. Am J Drug Deliv. 2006; 4: 153- 160.

[99] Souri H, Banerjee H, Jusufi A, et al. Wearable and stretchable strain sensors:materials, sensing mechanisms, and applications. Adv Intell Syst. 2020; 2: 2000039.

[100] Murugadoss G, Salla S, Kumar MR, et al. Decoration of ZnO surface with tiny sulfide-based nanoparticles for improve photocatalytic degradation efficiency. Environ Res. 2023; 220: 115171.

[101] Lou Z, Wang L, Shen G. Recent advances in smart wearable sensing systems. Adv Mater Technol. 2018; 3: 1800444.

[102] Tahara Y, Goto M. Recent advances of ionic liquids for transdermal drug delivery systems. Drug Deliv Syst. 2018; 33: 303- 310.

[103] Amjadi M, Kyung K, Park I, Sitti M. Stretchable, skin-mountable, and wearable strain sensors and their potential applications:a review. Adv Funct Mater. 2016; 26: 1678- 1698.

[104] Hill M, Connell M, DeCherney A. Recent advances in the development of transdermal delivery systems for treatment of infertility. Res Rep Transderm Drug Deliv. 2015; 4: 1- 7.

[105] Hirama H, Ishikura Y, Kano S, Hayase M, Mekaru H. Monodispersed sodium hyaluronate microcapsules for transdermal drug delivery systems. Mater Adv. 2021; 2: 7007- 7016.

[106] Drotlef D, Amjadi M, Yunusa M, Sitti M. Microfibers:bioinspired composite microfibers for skin adhesion and signal amplification of wearable sensors (adv. Mater. 28/2017). Adv Mater. 2017; 29: 1701353.

[107] Amjadi M, Mostaghaci B, Sitti M. Recent advances in skin penetration enhancers for transdermal gene and drug delivery. Curr Gene Ther. 2017; 17: 139- 146.

[108] Amjadi M, Sheykhansari S, Nelson BJ, Sitti M. Recent advances in wearable transdermal delivery systems. Adv Mater. 2018; 30: 1704530.

RIGHTS & PERMISSIONS

The Authors. Publishing services by Elsevier B.V. on behalf of Higher Education Press and KeAi Communications Co. Ltd.